Abstract | BACKGROUND & AIMS: METHODS: Forty RA patients supplemented their diet with either HMB/GLN/ARG or a nitrogen (7.19 g/day) and calorie (180 kcal/day) balanced mixture of alanine, glutamic acid, glycine, and serine (placebo) for 12 weeks. Body composition and other outcomes were assessed at baseline and follow-up, and analysed by mixed ANOVA. RESULTS: Dietary supplementation with HMB/GLN/ARG was not superior to placebo in the treatment of rheumatoid cachexia (groupxtime interactions P>0.05 for all outcomes). Both amino acid mixtures significantly increased (main effect of time) fat-free mass (727+/-1186 g, P<0.01), total body protein (719+/-1703 g, P=0.02), arms (112+/-183 g, P<0.01) and legs (283+/-534 g, P<0.01) lean mass, and some measures of physical function. No significant adverse event occurred during the study, but patients in the HMB/GLN/ARG group reported fewer gastrointestinal complaints compared to placebo. CONCLUSIONS: Dietary supplementation with HMB/GLN/ARG is better tolerated but not more effective in reversing cachexia in RA patients compared to the mixture of other non- essential amino acids used as placebo. Further controlled studies are necessary to confirm the beneficial anabolic and functional effects of increased nitrogen intake in this population.
|
Authors | Samuele Marcora, Andrew Lemmey, Peter Maddison |
Journal | Clinical nutrition (Edinburgh, Scotland)
(Clin Nutr)
Vol. 24
Issue 3
Pg. 442-54
(Jun 2005)
ISSN: 0261-5614 [Print] England |
PMID | 15896432
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Valerates
- Glutamine
- beta-hydroxyisovaleric acid
- Arginine
|
Topics |
- Arginine
(administration & dosage)
- Arthritis, Rheumatoid
(complications, metabolism, psychology)
- Body Composition
(physiology)
- Body Mass Index
- Cachexia
(diet therapy, etiology, psychology)
- Dietary Supplements
- Double-Blind Method
- Female
- Glutamine
(administration & dosage)
- Hand Strength
(physiology)
- Humans
- Male
- Middle Aged
- Surveys and Questionnaires
- Valerates
(administration & dosage)
|